Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives

被引:21
作者
Cottin, Vincent [1 ,2 ,3 ]
Martinez, Fernando J. [4 ]
Smith, Vanessa [5 ,6 ,7 ,8 ]
Walsh, Simon L. F. [9 ]
机构
[1] Hosp Civils Lyon, Louis Pradel Hosp, Reference Ctr Rare Pulm Dis, Lyon, France
[2] Claude Bernard Univ Lyon 1, INRAE, UMR754, OrphaLung,RespiFil,Rad ILD, Lyon, France
[3] Claude Bernard Univ Lyon 1, ERN LUNG, Lyon, France
[4] Cornell Univ, Dept Med, New York, NY 10021 USA
[5] Ghent Univ Hosp, Dept Rheumatol, Dept Internal Med, Ghent, Belgium
[6] Univ Ghent, Dept Internal Med, Ghent, Belgium
[7] VIB Inflammat Res Ctr IRC, Unit Mol Immunol & Inflammat, Ghent, Belgium
[8] ERN ReCONNET Rare Connect Tissue Dis, Ghent, Belgium
[9] Imperial Coll London, Natl Heart & Lung Inst, London, England
关键词
IDIOPATHIC PULMONARY-FIBROSIS; THORACIC SOCIETY; DOUBLE-BLIND; UNMET NEEDS; DIAGNOSIS; MANAGEMENT; PNEUMONIA; WORKING; PIRFENIDONE; PREDICTORS;
D O I
10.1183/16000617.0003-2022
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Multidisciplinary team (MDT) meetings, involving the integrated collaboration of healthcare professionals, are increasingly used in clinical practice to inform the diagnosis and treatment of interstitial lung diseases (ILDs). Over time, the assessment of patients with ILD has transitioned from discussions among clinicians, radiologists and pathologists to the inclusion of a broader range of clinical data and specialist expertise. Studies have shown that a multidisciplinary approach can have many benefits for the clinical care of patients with ILD by improving the diagnostic confidence for different ILDs and guiding treatment decisions. The utility of MDT discussions for diagnosis, monitoring disease progression and management decisions, will need to be considered based on how it is best positioned in the diagnostic and therapeutic process, as well as the practicality and challenges of its use. There are also uncertainties and heterogeneity concerning the optimal practices of MDT meetings in ILD care. In this review, we describe recent developments refining the approach to MDTs in clinical practice, including who should be involved in the MDTs, when it is most needed, their use in patient management, challenges in their implementation, and ongoing controversies in the field that need further research.
引用
收藏
页数:19
相关论文
共 97 条
  • [1] Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis
    Adderley, Nicola
    Humphreys, Christopher J.
    Barnes, Hayley
    Ley, Brett
    Premji, Zahra A.
    Johannson, Kerri A.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (02)
  • [2] The Impact of Multidisciplinary Discussion (MDD) in the Diagnosis and Management of Fibrotic Interstitial Lung Diseases
    Ageely, Ghofran
    Souza, Carolina
    De Boer, Kaissa
    Zahra, Saly
    Gomes, Marcio
    Voduc, Nha
    [J]. CANADIAN RESPIRATORY JOURNAL, 2020, 2020
  • [3] [Anonymous], 2002, Am J Respir Crit Care Med, V165, P277304, DOI [10.1164/ajrccm.165.2.ats01, DOI 10.1164/AJRCCM.165.2.ATS01]
  • [4] Autorite de Sante Haute, FIBR PULM ID
  • [5] Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
    Behr, Juergen
    Prasse, Antje
    Kreuter, Michael
    Johow, Johannes
    Rabe, Klaus F.
    Bonella, Francesco
    Bonnet, Reiner
    Grohe, Christian
    Held, Matthias
    Wilkens, Heinrike
    Hammerl, Peter
    Koschel, Dirk
    Blaas, Stefan
    Wirtz, Hubert
    Ficker, Joachim H.
    Neumeister, Wolfgang
    Schoenfeld, Nicolas
    Claussen, Martin
    Kneidinger, Nikolaus
    Frankenberger, Marion
    Hummler, Simone
    Kahn, Nicolas
    Tello, Silke
    Freise, Julia
    Welte, Tobias
    Neuser, Petra
    Guenther, Andreas
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (05) : 476 - 486
  • [6] Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Belhassen, Manon
    Dalon, Faustine
    Nolin, Maeva
    Van Ganse, Eric
    [J]. RESPIRATORY RESEARCH, 2021, 22 (01)
  • [7] Biglia C, 2019, SARCOIDOSIS VASC DIF, V36, P108, DOI 10.36141/svdld.v36i2.8107
  • [8] European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers
    Bonella, Francesco
    Wijsenbeek, Marlies
    Molina-Molina, Maria
    Duck, Annette
    Mele, Rosalba
    Geissler, Klaus
    Wuyts, Wim
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (02) : 597 - 606
  • [9] Brown KK, 2020, EUR RESPIR J, V55
  • [10] Histologist's original opinion compared with multidisciplinary team in determining diagnosis in interstitial lung disease
    Burge, P. S.
    Reynolds, J.
    Trotter, S.
    Burge, G. A.
    Walters, G.
    [J]. THORAX, 2017, 72 (03) : 280 - 281